Target intelligence / Profile preview

Nicotinic Acetylcholine Receptor Subunit Alpha-4 Beta-2 (α4β2 nAChR)

Target
α4β2 nAChR
Molecular classification
Ligand-gated ion channel, Nicotinic acetylcholine receptor, Receptor
01

Overview

The α4β2 nicotinic acetylcholine receptor (α4β2 nAChR) is a pentameric ligand-gated ion channel composed of alpha-4 (CHRNA4) and beta-2 (CHRNB2) subunits. It is the most abundant nicotinic receptor subtype in the mammalian brain and plays a central role in mediating the effects of nicotine, including its addictive properties. The receptor is implicated in cognitive processes such as learning and attention, as well as growth hormone secretion. Upon binding acetylcholine or agonists like nicotine, the receptor undergoes conformational changes that open its ion channel, allowing Na^+ and K^+ ions to flow across neuronal membranes. This leads to neuronal excitation both pre-synaptically and post-synaptically. Activation enhances neurotransmitter release and modulates synaptic plasticity. Mutations in CHRNA4 have been linked with autosomal dominant nocturnal frontal lobe epilepsy and paroxysmal kinesogenic dyskinesia.

Other names
CHRNA4/CHRNB2 receptoralpha4beta2 nicotinic receptor
02

Mechanism of action

Agonist-induced opening of cation channel allowing Na^+ and K^+ influx, leading to neuronal excitation; partial agonism modulating receptor activity.

03

Biological functions

Fast synaptic transmissionNeuronal excitationNeurotransmitter release modulationSynaptic plasticityGrowth hormone secretionIon channel activity
04

Disease associations

AddictionAutosomal dominant nocturnal frontal lobe epilepsyParoxysmal kinesogenic dyskinesiaCognitive impairmentObesity predisposition
05

Safety considerations

Desensitization leading to toleranceUpregulation contributing to dependenceEpileptic seizures (in CHRNA4 mutation carriers)Dyskinesia (in CHRNA4 mutation carriers)
06

Interacting drugs

Acetylcholine

2 more in the full profile.

Beyond the preview

Go deeper on Nicotinic Acetylcholine Receptor Subunit Alpha-4 Beta-2 (α4β2 nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic Acetylcholine Receptor Subunit Alpha-4 Beta-2 (α4β2 nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call